* Telesis Bio Inc TBIO.OQ TBIO.O is expected to show a
rise in
quarterly revenue when it reports results on May 10 (estimated)
for the period ending March 31 2024
* The San Diego California-based company is expected to
report a
9.2% increase in revenue to $6.9 million from $6.32 million a
year ago, according to the estimate from one analyst, based on
LSEG data.
* LSEG's mean analyst estimate for Telesis Bio Inc is for a
loss
of 23 cents per share.
* The one available analyst rating on the shares is "buy".
* The mean earnings estimate of analysts was unchanged in
the last
three months.
This summary was machine generated May 8 at 12:56 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)